211 related articles for article (PubMed ID: 27468416)
1. A novel approach for next-generation sequencing of circulating tumor cells.
Yee SS; Lieberman DB; Blanchard T; Rader J; Zhao J; Troxel AB; DeSloover D; Fox AJ; Daber RD; Kakrecha B; Sukhadia S; Belka GK; DeMichele AM; Chodosh LA; Morrissette JJ; Carpenter EL
Mol Genet Genomic Med; 2016 Jul; 4(4):395-406. PubMed ID: 27468416
[TBL] [Abstract][Full Text] [Related]
2. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
[TBL] [Abstract][Full Text] [Related]
3. Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.
Liu HE; Triboulet M; Zia A; Vuppalapaty M; Kidess-Sigal E; Coller J; Natu VS; Shokoohi V; Che J; Renier C; Chan NH; Hanft VR; Jeffrey SS; Sollier-Christen E
NPJ Genom Med; 2017; 2():34. PubMed ID: 29263843
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.
De Luca G; Cardinali B; Del Mastro L; Lastraioli S; Carli F; Ferrarini M; Calin GA; Garuti A; Mazzitelli C; Zupo S; Dono M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575430
[TBL] [Abstract][Full Text] [Related]
5. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells.
Babayan A; Alawi M; Gormley M; Müller V; Wikman H; McMullin RP; Smirnov DA; Li W; Geffken M; Pantel K; Joosse SA
Oncotarget; 2017 Aug; 8(34):56066-56080. PubMed ID: 28915574
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level.
Lu S; Chang CJ; Guan Y; Szafer-Glusman E; Punnoose E; Do A; Suttmann B; Gagnon R; Rodriguez A; Landers M; Spoerke J; Lackner MR; Xiao W; Wang Y
J Mol Diagn; 2020 Jun; 22(6):770-781. PubMed ID: 32247862
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
9. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
12. Assessment of REPLI-g Multiple Displacement Whole Genome Amplification (WGA) Techniques for Metagenomic Applications.
Ahsanuddin S; Afshinnekoo E; Gandara J; Hakyemezoğlu M; Bezdan D; Minot S; Greenfield N; Mason CE
J Biomol Tech; 2017 Apr; 28(1):46-55. PubMed ID: 28344519
[TBL] [Abstract][Full Text] [Related]
13. A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity.
Deger T; Mendelaar PAJ; Kraan J; Prager-van der Smissen WJC; van der Vlugt-Daane M; Bindels EMJ; Sieuwerts AM; Sleijfer S; Wilting SM; Hollestelle A; Martens JWM
Mol Oncol; 2022 Aug; 16(16):2981-3000. PubMed ID: 34964258
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Stover EH; Oh C; Keskula P; Choudhury AD; Tseng YY; Adalsteinsson VA; Lohr JG; Thorner AR; Ducar M; Kryukov GV; Ha G; Rosenberg M; Freeman SS; Zhang Z; Wu X; Van Allen EM; Takeda DY; Loda M; Wu CL; Taplin ME; Garraway LA; Boehm JS; Huang FW
Prostate; 2022 Apr; 82(5):584-597. PubMed ID: 35084050
[TBL] [Abstract][Full Text] [Related]
16. Optimized Workflow for Whole Genome and Transcriptome Next-Generation Sequencing of Single Cells or Limited Nucleic Acid Samples.
Andreou I; Storbeck M; Hahn P; Rulli S; Lader E
Curr Protoc; 2023 May; 3(5):e753. PubMed ID: 37166214
[TBL] [Abstract][Full Text] [Related]
17. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.
Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT
Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
19. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
20. Detection of
Rodriguez BJ; Córdoba GD; Aranda AG; Álvarez M; Vicioso L; Pérez CL; Hernando C; Bermejo B; Parreño AJ; Lluch A; Ryder MB; Jones FS; Fredebohm J; Holtrup F; Queipo-Ortuño MI; Alba E
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31394872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
